Paul Tudor Jones Pfizer Inc Put Options Transaction History

Tudor Investment Corp Et Al

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $10.4 Million - $11.8 Million	-376,800 Reduced 41.78%	525,100 $15.2 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $2.18 Million - $2.56 Million	-86,500 Reduced 8.75%	901,900 $25.2 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $1.96 Million - $2.25 Million	75,800 Added 8.31%	988,400 $27.4 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $16.7 Million - $21.6 Million	637,500 Added 231.73%	912,600 $26.3 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $3.57 Million - $4.17 Million	111,200 Added 67.85%	275,100 $9.13 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $5.49 Million - $6.36 Million	152,100 Added 1288.98%	163,900 $6.01 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $464,802 - $605,104	11,800 New	11,800 $480,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $6.53 Million - $9.68 Million	-158,000 Reduced 93.05%	11,800 $697,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $6.66 Million - $8.56 Million	169,800 New	169,800 $7.31 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.